CHIESI FARMACEUTICI S.P.A.
- Country
- 🇸🇪Sweden
- Ownership
- -
- Established
- 1935-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.chiesigroup.com
Dose Finding Study of CHF 4226 for Treating Patients With COPD
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- First Posted Date
- 2008-01-31
- Last Posted Date
- 2017-04-11
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 278
- Registration Number
- NCT00605891
- Locations
- 🇨🇿
Ordinace pro nemoci dychaciho ustroji, Beroun, Czech Republic
🇺🇸University Clinical Research - DeLand, LLC, DeLand, Florida, United States
🇵🇱NZOZ Non-nocere, Gdansk, Poland
Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma
- Conditions
- Bronchial Asthma
- Interventions
- First Posted Date
- 2007-09-12
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 180
- Registration Number
- NCT00528723
- Locations
- 🇮🇹
Unità Operativa Complessa di Clinica fisiologica e Pneumologia - Dipartimento di Medicina Interna e Specialità Mediche (DI.MI.) - Ospedale S. Martino e Cliniche Universitarie Convenzionate, Genova, Italy
🇷🇺City Clinical Hospital № 61, Pulmonology Department, Moscow, Russian Federation
🇪🇸Hospital General Universitario Gregorio Marañón, Madrid, Spain
Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- Drug: Poractant alfa (Curosurf®)
- First Posted Date
- 2007-07-17
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 208
- Registration Number
- NCT00501982
- Locations
- 🇵🇹
Maternidade Alfredo da Costa, Lisbon, Portugal
🇪🇸Hospital De Cruces, Bilbao, Spain
🇨🇿General Faculty Hospital, Prague, Czechia
Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms
- Conditions
- Bronchial Asthma
- Interventions
- Drug: Beclomethasone dipropionate/Salbutamol combination
- First Posted Date
- 2007-07-06
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 283
- Registration Number
- NCT00497523
- Locations
- 🇵🇱
Zaklad Alergologii Dzieciecej, Bialystok, Poland
🇵🇱Wojskovy Szpital Klinikzny, Krakow, Poland
🇵🇱Priwtny Gabinet Pediatriczno - Alergologiczny, Rabka Zdroj, Poland
Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
- Conditions
- Asthma
- Interventions
- Drug: Beclomethasone plus formoterol fixed combination
- First Posted Date
- 2007-07-06
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 382
- Registration Number
- NCT00497237
- Locations
- 🇮🇹
Ospedale Cardarelli - Fisiopatologia Respiratoria, Napoli, Italy
🇺🇦Department of Diagnostic, Therapy and Clinical Pharmacology of Lung Diseases of the Institute of Phthisiology and Pulmonology Academy of Medical Science of the Ukraine, Kiev, Ukraine
🇮🇹CNR - Dipartimento di Fisiopatologia Respiratoria, Palermo, Italy
Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma
- Conditions
- Asthma
- Interventions
- Drug: Beclometasone dipropionate 250 µg/unit dose pMDIDrug: beclomethasone/formoterol (100/6µg) pMDI
- First Posted Date
- 2007-05-21
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 824
- Registration Number
- NCT00476268
Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Drug: Beclomethasone 100 µg plus formoterol 6 µg (CHF1535) pMDI
- First Posted Date
- 2007-05-21
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 828
- Registration Number
- NCT00476099
- Locations
- 🇫🇷
Thomas Similowski, Paris, France
Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)
- Conditions
- Bronchial Asthma
- Interventions
- Drug: beclomethasone dipropionate plus formoterol fumarate combination
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 219
- Registration Number
- NCT00413387
- Locations
- 🇦🇹
Ambulance For Paediatric and Pulmonology, Wien, Austria
🇵🇱Prywatny Gabinet Lekarski, Lodz, Poland
🇵🇱Nzoz "Medex"Poradnia Alergologiczna, Bielsko-Biala, Poland
EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI
- Conditions
- Bronchial Asthma
- First Posted Date
- 2006-11-01
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 180
- Registration Number
- NCT00394368
- Locations
- 🇵🇱
Dolnoslaski Centre of Medical Diagnostic "Dolmed", Wroclaw, Poland
🇺🇦Kharkiv City Clinical Hospital 13 Pulmonological Department, Kharkiv, Ukraine
🇺🇦Institute of Phthisiology and Pulmonology, Academy of Medical Science of Ukraine, Depatment of Diagnostic, Therapy and Clinical Pharmacology of Lung Disease, Kiev, Ukraine
As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma
- Conditions
- Asthma
- First Posted Date
- 2006-10-02
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 480
- Registration Number
- NCT00382889
- Locations
- 🇵🇱
Clinic of Infection Diseases and Allergology - Central Clinical Hospital of Military Medical Academy, Warszawa, Poland
🇦🇹Pulmologisches Zentrum Der Stadt Wien, Wien, Austria
🇵🇱Specialist Group Medex, Bielsko Biala, Poland